Eduardo Arellano‐Rodrigo

Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.

Eduardo Arellano‐Rodrigo, Alberto Álvarez‐Larrán, Neus Villamor et al. · PubMed · 2006 · 275 citations

Medicine, Hematology, Pathology +17

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

Alberto Álvarez‐Larrán, Francisco Cervantes, Arturo Pereira et al. · Blood · 2010 · 234 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Álvarez‐Larrán, Arturo Pereira, Francisco Cervantes et al. · Blood · 2011 · 227 citations · Full text

Medicine, Hematology, Oncology +6

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

Truman J. Milling, Saskia Middeldorp, Lizhen Xu et al. · Circulation · 2023 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients

Alejandra Martínez‐Trillos, Anna Gayà, Margherita Maffioli et al. · Annals of Hematology · 2010 · 147 citations · Full text

Medicine, Hematology, Pharmacology +11